ArticleJournal of cell communication and signaling2025
Nuclear binding SET domain 1 alleviates cartilage ferroptosis in knee osteoarthritis by upregulating the krüppel-like factor 9/autophagy-related 14 pathway via H3K36me2 modification.
Article in Journal of cell communication and signaling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The ATG14: multi-layer autophagy control and an emerging therapeutic target in cancer.Apoptosis : an international journal on programmed cell death · 2026Review
- Research progress on the mechanism of chondrocyte ferroptosis in osteoarthritis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Knee osteoarthritis (KOA) is a progressive disease featured by cartilage damage. This study attempts to explore the role of nuclear binding SET domain 1 (NSD1) in KOA cartilage ferroptosis, thereby finding a new target for KOA treatment. Pathological changes, cartilage damage, and inflammatory cytokine levels in the established KOA mouse model were assessed. Primary mouse knee chondrocytes were separated, cultured, and challenged with IL-1β to establish in vitro KOA models. Cell viability was determined, Reactive oxygen species levels and ferroptosis-related factors were measured after interventions with NSD1, krüppel-like factor 9 (KLF9), and acyl-CoA synthetase long-chain family member 4 (ATG14). Furthermore, the enrichment of NSD1 and H3K36me2 on the KLF9 promoter as well as the enrichment of KLF9 on the ATG14 promoter was analyzed. Binding site between KLF9 and ATG14 promoter was assessed. NSD1 was downregulated in KOA mouse cartilage tissues and IL-1β-challenged chondrocytes. KOA severity was alleviated, chondrocyte viability was promoted, and ferroptosis was quenched after NSD1 overexpression. NSD1 strengthened H3K36me2 to upregulate KLF9 expression, and KLF9 transcriptionally activated ATG14 expression. KLF9 or ATG14 knockdown could both partially reverse the protective role of NSD1 overexpression on KOA cartilage ferroptosis. NSD1 enhanced KLF9 expression to improve ATG14 expression via H3K36me2 modification, thus relieving KOA cartilage ferroptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.